The RBV Blog

Check this out. What you will see are descriptions of new high-tech hospital “behavioral health areas” being instituted by some hospitals to promote “calmness” in young, agitated patients awaiting care.  This makes a lot of sense. Juxtapose the spaces described in this article, that can be custom-tailored to meet the psychological needs of a specific […]

Check this out. What you will see is a write-up that is interesting in several different ways. First, as the writer tells the story, the interest surrounding Molnupiravir, Merck’s much anticipated therapy for COVID-19, has captured analysts’ focus far more than the overall quarterly performance of the giant drug company. How those two factor will […]

Check this out. A dollop of common sense here. Words are always important. We have sort of known all along that the specific words we choose to make a point can be our best friends or our worst enemies.  But the COVID-19 pandemic has given this concept new meaning. Think about the word “mandate.” As […]

Check this out. What you will see will not shock you in terms of substance. Sure, hacking can be done. No surprise there.  BUT. This piece may surprise you in terms of the order of magnitude of the problems encountered with patient data platforms. One login permits access to 4 million patient records. Cybercriminals scoring $21B […]

Check this out. What you will see is some mildly interesting stuff concerning telehealth. Skip over that and go to the section on VACCINE HESITANCY.  There you will find some interesting numbers. More specifically, you will see that 52% of physicians believe that they need 2-3 conversations with patients to change their minds about vaccinations, […]

Check this out. What you will see, unless I am missing something, is a statement of the obvious. To me not surprising is the fact that Biogen reported Aduhelm sales of a mere $300,000 for 3rd quarter 2021. Somewhat more surprising was that this was up against analysts’ consensus of $14 Million. Yup, sometimes things […]

Want a good smack in the face with some good old-fashioned common sense? Check this out. What you will see is an article that reviews the impact of NYU’s Grossman Medical School giving, starting in 2018, all current and future medical students free tuition. A generous move for sure, and one likely to attract medical […]

In our previous post, we talked about the need for pharma to be increasingly creative in its “visual storytelling” if it expects to get its message across to jaded consumers in this Zoom fatigued, hyper video streaming world. So here is a great example. What you see here is Teva going all out to communicate […]

Check this out. What you will see is a piece on how pharma needs to work extra hard in 2021 to capture attention. Much of our population suffers from pandemic-induced Zoom fatigue. Virtually everyone is awash in streaming media from hundreds of sources. The result? The bar for attention-grabbing has been raised significantly. What to […]